In a bold move shaking up the weight loss industry, telehealth giant Hers has launched a new prescription injection offering similar benefits to the viral drug Ozempic – at a fraction of the price.
The Ozempic Alternative Making Waves
Priced at just $249 per month, Hers' semaglutide injection undercuts Ozempic's typical $900+ price tag while delivering comparable appetite-suppressing effects. The treatment mimics GLP-1 hormones to slow digestion and reduce cravings.
How It Works
- Weekly self-administered injections
- Gradual dose escalation over 16-20 weeks
- Requires telehealth consultation for prescription
Medical Experts Weigh In
"While promising, these medications aren't magic bullets," cautions Dr. Emily Harrison, bariatric specialist. "Patients must commit to lifestyle changes for sustainable results."
The treatment comes with potential side effects including nausea, constipation and, in rare cases, pancreatitis. Hers recommends close medical supervision throughout the program.
Accessibility vs. Safety Concerns
Some UK health professionals express concern about easy digital access to potent medications. "These drugs require proper patient screening," notes NHS endocrinologist Dr. Raj Patel.
Hers maintains rigorous prescription protocols, requiring comprehensive health evaluations before approving treatment.
